Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.

Fabian D, Wild C

Open source

DOI
10.1080/20523211.2026.2659063
Published
2026
Container
Journal of pharmaceutical policy and practice
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20523211.2026.2659063,
  title = {Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.},
  author = {Fabian D and Wild C},
  year = {2026},
  journal = {Journal of pharmaceutical policy and practice},
  doi = {10.1080/20523211.2026.2659063},
  url = {https://doi.org/10.1080/20523211.2026.2659063}
}

RIS

TY  - JOUR
TI  - Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.
AU  - Fabian D
AU  - Wild C
PY  - 2026
JO  - Journal of pharmaceutical policy and practice
DO  - 10.1080/20523211.2026.2659063
UR  - https://doi.org/10.1080/20523211.2026.2659063
ER  - 

APA

D, F., & C, W. (2026). Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.. Journal of pharmaceutical policy and practice. https://doi.org/10.1080/20523211.2026.2659063

Source records